RAPT
RAPT Therapeutics Inc.
$20.13
+$0.27(+1.36%)
50
Overall
--
Value
50
Tech
--
Quality
Market Cap
$291.56M
Volume
207.30K
52W Range
$5.66 - $26.56
Target Price
$23.60
Order:
Income Statement
| Metric | Trend | Chart | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||
| Total Revenue | -- | $5.0M | $3.8M | $1.5M | -- | -- | ||
| Total Revenue | -- | $5.0M | $3.8M | $1.5M | -- | -- | ||
| GROSS PROFIT | ||||||||
| Gross Profit | -- | $5.0M | $3.8M | $1.5M | -- | -- | ||
| OPERATING EXPENSES | ||||||||
| Operating Expenses | $-43.6M | $58.3M | $73.0M | $87.3M | $127.1M | $136.1M | ||
| Research & Development | $34.9M | $45.5M | $57.0M | $67.1M | $101.0M | $107.2M | ||
| Research Expense | $34.9M | $45.5M | $57.0M | $67.1M | $101.0M | $107.2M | ||
| Selling, General & Administrative | $8.7M | $12.8M | $16.0M | $20.2M | $26.1M | $28.9M | ||
| General & Administrative Expenses | $8.7M | $12.8M | $16.0M | $20.2M | $26.1M | $28.9M | ||
| Salaries & Wages | $-2.1M | -- | -- | -- | $17.1M | $19.9M | ||
| Depreciation & Amortization | $-1.3M | $1.1M | $1.0M | $1.0M | $1.2M | $1.2M | ||
| Depreciation & Amortization | $-1.3M | $1.1M | $1.0M | $1.0M | $1.2M | $1.2M | ||
| Other Operating Expenses | $-466.0K | $-544.0K | $-1.3M | $-759.0K | $-1.0M | $-905.0K | ||
| OPERATING INCOME | ||||||||
| Operating income | $-43.6M | $-53.2M | $-69.2M | $-85.8M | $-127.1M | $-136.1M | ||
| EBITDA | $-41.0M | $-52.1M | $-68.2M | $-83.1M | $-115.6M | $-128.7M | ||
| NON-OPERATING ITEMS | ||||||||
| Intinc | $1.3M | -- | -- | -- | -- | -- | ||
| Net Non-Operating Interest Income/Expense | $1.3M | -- | -- | -- | -- | -- | ||
| Other Income/Expense | -- | $-1.3M | $-5.0K | $-2.0M | $-10.3M | $-6.2M | ||
| Other Special Charges | -- | $1.3M | $5.0K | $2.0M | $10.3M | $6.2M | ||
| PRE-TAX INCOME | ||||||||
| EBIT | $-42.3M | $-53.2M | $-69.2M | $-83.8M | $-116.8M | $-129.9M | ||
| Pre-Tax Income | $-42.3M | $-51.9M | $-69.2M | $-83.8M | $-116.8M | $-129.9M | ||
| INCOME TAX | ||||||||
| Tax Provision | $660.0K | $990.0K | -- | -- | -- | -- | ||
| NET INCOME | ||||||||
| Net Income | $-43.0M | $-52.9M | $-69.2M | $-83.8M | $-116.8M | $-129.9M | ||
| Net Income (Continuing Operations) | $-43.0M | $-52.9M | $-69.2M | $-83.8M | $-116.8M | $-129.9M | ||
| Net Income (Discontinued Operations) | $-43.0M | $-52.9M | $-69.2M | $-83.8M | $-116.8M | $-129.9M | ||
| Net Income (Common Stockholders) | $-43.0M | $-52.9M | $-69.2M | $-83.8M | $-116.8M | $-129.9M | ||
| Normalized Income | -- | -- | $-54.7M | $-66.2M | -- | $-128.6M | ||
| TOTALS | ||||||||
| Total Expenses | $-43.6M | $58.3M | $73.0M | $87.3M | $127.1M | $136.1M | ||
| SHARE & EPS DATA | ||||||||
| Average Shares Outstanding | $543.3K | $3.0M | $3.4M | $32.5M | $4.8M | $40.8M | ||
| Average Shares Outstanding (Diluted) | $543.4K | $3.0M | -- | $32.5M | $4.8M | $40.8M | ||
| Shares Outstanding | $3.0M | $3.1M | $3.7M | $34.3M | $4.3M | $132.0M | ||
| Basic EPS | -- | $-17.52 | $-20.24 | $-2.58 | $-24.4 | $-3.19 | ||
| Basic EPS (Continuing Operations) | -- | $-17.52 | $-20.24 | $-2.58 | $-24.4 | $-3.19 | ||
| Diluted EPS | $79.12 | $-17.52 | $-20.24 | $-2.58 | $-24.4 | $-3.19 | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | $-2.58 | $-24.4 | $-3.19 | ||
| OTHER METRICS | ||||||||
| Other Gand A | $8.7M | $12.8M | $16.0M | $20.2M | $26.1M | $28.9M | ||
| Rent And Landing Fees | $8.7M | -- | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RAPT | $20.13 | +1.4% | 207.30K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |